SINGAPORE (Nov 21): Pharmaceutical company iX Biopharma announced that it has been granted a patent in South Africa for its WaferiX drug delivery technology. The patent will expire on Oct 26, 2030.

WaferiX is a fast-dissolving wafer formulation that allows drugs to be administered by placing under the tongue.

iX Biopharma’s pipeline of products under development includes Wafermine and BnoX for pain management and PheoniX for erectile dysfunction.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook